| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |